Literature DB >> 24787362

The effect of surgeon experience on the detection of metastatic lymph nodes in the central compartment and the pathologic features of clinically unapparent metastatic lymph nodes: what are we missing when we don't perform a prophylactic dissection of central compartment lymph nodes in papillary thyroid cancer?

Sophie Scherl1, Saral Mehra, Jason Clain, Laura L Dos Reis, Mark Persky, Andrew Turk, Bruce Wenig, Hasan Husaini, Mark L Urken.   

Abstract

BACKGROUND: Prophylactic central neck dissection (PCND) for papillary thyroid cancer (PTC) is controversial. Recent publications suggest that the number and size of nodes and the presence of extranodal extension (ENE) are important features for risk stratification of lymph node metastases. We analyzed these features in clinically unapparent nodes that would not otherwise be removed. We also investigated the impact of surgeon experience on the ability to detect metastatic lymph nodes intraoperatively.
METHODS: Forty-seven patients with well-differentiated PTC, with no preoperative evidence of central metastases, were included in this study. Intraoperatively, clinically apparent disease was determined by inspection and palpation by the senior surgeon and a fellow/senior resident, and recorded in a blinded fashion. Rate of occult metastases based on intraoperative evaluation were tabulated for each group of surgeons. Histopathologic features of occult nodes were analyzed to determine what clinicians would be missing by foregoing a PCND, and how that would have impacted the patient management.
RESULTS: The rate of occult metastases, based on senior surgeon assessment, was 26%, and did not differ significantly from fellow/senior resident assessment. The level of agreement between these two surgeon groups was moderate (k=0.665). Analysis of the false negative cases revealed that the size of the largest undetected node ranged from 0.1 to 1.3 cm; 36% of patients with occult metastases demonstrated five or more positive nodes, and 27% showed ENE. DISCUSSION: Clinical assessment based on intraoperative inspection and palpation had poor sensitivity and specificity in identifying metastatic central nodes, regardless of the level of experience of the surgeon. There was moderate agreement between surgeons of different experience levels. Sensitivity improved significantly with larger size of positive nodes, but not with the presence of multiple positive nodes or presence of ENE. In foregoing PCND in this patient population, our results suggest that treating clinicians miss potentially virulent disease with a large number of occult positive central nodes and occult nodes with ENE. This is the first report to address the pathologic features of clinically nonevident central nodes showing a high incidence of clinically relevant, adverse histologic features, as well as the impact of surgeon experience in performing the important intraoperative determination of whether there are clinically evident nodes that require removal.

Entities:  

Mesh:

Year:  2014        PMID: 24787362     DOI: 10.1089/thy.2013.0600

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  11 in total

1.  Quantification of lymph nodes in the central compartment of the neck: a cadaveric study.

Authors:  Enyinnaya Ofo; Selvam Thavaraj; Daron Cope; James Barr; Karan Kapoor; Jean-Pierre Jeannon; Richard Oakley; Claire Lock; Edward Odell; Ricard Simo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-20       Impact factor: 2.503

2.  Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.

Authors:  G Sapuppo; F Palermo; M Russo; M Tavarelli; R Masucci; S Squatrito; R Vigneri; G Pellegriti
Journal:  J Endocrinol Invest       Date:  2017-06-23       Impact factor: 4.256

3.  Intrathyroidal tumors presenting with extranodal extension: what are we missing?

Authors:  Jason B Clain; Saral Mehra; Sophie Scherl; Laura L Dos Reis; A Turk; Bruce M Wenig; Eliza H Dewey; Mark L Urken
Journal:  Endocr Pathol       Date:  2014-12       Impact factor: 3.943

4.  A Prediction Model for Contralateral Central Neck Lymph Node Metastases in Unilateral Papillary Thyroid Cancer.

Authors:  Hai-Long Tan; Bo-Qiang Huang; Gui-You Li; Bo Wei; Pei Chen; Hui-Yu Hu; Mian Liu; Deng-Jie Ou-Yang; Qiong Yang; Zi-En Qin; Qi-Man Shi; Ning Li; Peng Huang; Shi Chang
Journal:  Int J Endocrinol       Date:  2021-06-30       Impact factor: 3.257

5.  A National Comparison of Operative Outcomes of New and Experienced Surgeons.

Authors:  Rachel R Kelz; Morgan M Sellers; Bijan A Niknam; James E Sharpe; Paul R Rosenbaum; Alexander S Hill; Hong Zhou; Lauren L Hochman; Karl Y Bilimoria; Kamal Itani; Patrick S Romano; Jeffrey H Silber
Journal:  Ann Surg       Date:  2021-02-01       Impact factor: 13.787

6.  The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese Patients.

Authors:  Li-Bo Yang; Lin-Yong Sun; Yong Jiang; Ying Tang; Zhi-Hui Li; Hong-Ying Zhang; Hong Bu; Feng Ye
Journal:  Int J Endocrinol       Date:  2015-07-27       Impact factor: 3.257

7.  Evaluation of accuracy of one-step nucleic acid amplification (OSNA) in diagnosis of lymph node metastases of papillary thyroid carcinoma. Diagnostic study.

Authors:  Fabio Medas; Pierpaolo Coni; Francesco Podda; Claudia Salaris; Federico Cappellacci; Gavino Faa; Pietro Giorgio Calò
Journal:  Ann Med Surg (Lond)       Date:  2019-08-21

Review 8.  Prophylactic Central Neck Dissection in Well-differentiated Thyroid Cancer.

Authors:  Krešimir Gršić; Boris Bumber; Renata Curić Radivojević; Dinko Leović
Journal:  Acta Clin Croat       Date:  2020-06       Impact factor: 0.780

9.  Lymph node metastasis characteristics of papillary thyroid carcinoma located in the isthmus: A single-center analysis.

Authors:  Genpeng Li; Jianyong Lei; Qian Peng; Ke Jiang; Wenjie Chen; Wanjun Zhao; Zhihui Li; Rixiang Gong; Tao Wei; Jingqiang Zhu
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

10.  Risk Factors for Central Lymph Node Metastases and Benefit of Prophylactic Central Lymph Node Dissection in Middle Eastern Patients With cN0 Papillary Thyroid Carcinoma.

Authors:  Sandeep Kumar Parvathareddy; Abdul K Siraj; Saeeda O Ahmed; Felisa DeVera; Saif S Al-Sobhi; Fouad Al-Dayel; Khawla S Al-Kuraya
Journal:  Front Oncol       Date:  2022-01-17       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.